Microbix Biosystems Inc.
MBXBF · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $47 | $43 | $70 | $71 |
| - Cash | $13 | $12 | $13 | $10 |
| + Debt | $6 | $7 | $6 | $8 |
| Enterprise Value | $40 | $38 | $62 | $69 |
| Revenue | $25 | $17 | $19 | $19 |
| % Growth | 53.8% | -13.4% | 2.6% | – |
| Gross Profit | $15 | $7 | $11 | $11 |
| % Margin | 60.6% | 45.3% | 58.3% | 59.4% |
| EBITDA | $6 | $2 | $3 | $6 |
| % Margin | 24.4% | 11.9% | 17.4% | 30.4% |
| Net Income | $4 | -$0 | $2 | $2 |
| % Margin | 13.9% | -0.2% | 9.4% | 8.8% |
| EPS Diluted | 0.026 | -0 | 0.013 | 0.012 |
| % Growth | 8,633.3% | -102.4% | 9.6% | – |
| Operating Cash Flow | $4 | -$1 | $3 | $2 |
| Capital Expenditures | -$2 | -$1 | -$2 | -$1 |
| Free Cash Flow | $2 | -$2 | $1 | $1 |